Leonardo Vando
About Leonardo Vando
Leonardo Vando serves as the Medical Director at Mindbloom since 2020 and has over 16 years of experience as a psychiatrist and addiction psychiatrist at DR. VANDO MEDICAL SERVICES, PC. He specializes in treating complex psychiatric and addictive disorders and contributes to psychedelic medicine research, particularly in microdosing for mental illness.
Work at Mindbloom
Leonardo Vando has served as the Medical Director at Mindbloom since 2020. In this role, he oversees the clinical aspects of the organization, focusing on innovative treatments for mental health conditions. His work at Mindbloom emphasizes the integration of psychedelic medicine into therapeutic practices, particularly in the context of improving patient outcomes.
Current Role at DR. VANDO MEDICAL SERVICES, PC
Since 2008, Leonardo Vando has worked as a Psychiatrist and Addiction Psychiatrist at DR. VANDO MEDICAL SERVICES, PC. With over 16 years of experience in this capacity, he specializes in treating psychiatric and addictive disorders. His extensive practice includes developing treatment protocols that address complex conditions.
Education and Expertise
Leonardo Vando completed his Doctor of Medicine (M.D.) degree at Ponce School of Medicine. He furthered his education at Beth Israel Medical Center, where he participated in the Addiction Psychiatry Residency Program from 2001 to 2005. He also attended Sacred Heart University for his undergraduate studies in chemistry, laying a strong foundation for his medical career.
Contributions to Psychedelic Medicine
Leonardo Vando contributes to the field of psychedelic medicine through his research on microdosing for mental illness. His work aims to explore the therapeutic potential of psychedelics in treating various mental health conditions. He has developed intramuscular ketamine protocols designed to achieve rapid results while minimizing adverse events, particularly for treatment-resistant depression and addictive disorders.
Focus on Access to Treatment
Leonardo Vando is dedicated to increasing access to mental health treatment in low-income communities. His efforts include the implementation of ketamine protocols that provide effective care to underserved populations. He emphasizes the importance of integrating genetic, metabolic, cultural, and psychosocial data in the treatment of complex psychiatric conditions.